Mood Lifters Online for Graduate Students and Young Professionals

Sponsor
University of Michigan (Other)
Overall Status
Recruiting
CT.gov ID
NCT05078450
Collaborator
(none)
180
1
3
15.3
11.8

Study Details

Study Description

Brief Summary

Mood Lifters is a revolutionary mental wellness program that teaches scientifically validated strategies in a supportive group setting. This study will test two new versions of the program designed specifically for graduate students and young professionals.

Participants will need to attend 12 hour long virtual weekly meetings on Zoom that focus on helpful mental health strategies and skills. Participants will be encourage to practice what the participants learn at home in order to improve their mood or mental wellness. Additionally, participants will complete a series of measures (approx. 1-1.5 hours) prior to, at the end of the program, 1 month after the program and 6 months after the program.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mood Lifters
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
180 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Mood Lifters Online
Actual Study Start Date :
Sep 22, 2021
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Graduate Student Program

This is the graduate student version of the program. The original program has been tailored to this population to meet its specific needs and address its specific concerns.

Behavioral: Mood Lifters
Participants will need to attend 12 hour long virtual weekly meetings on Zoom that focus on helpful mental health strategies and skills. Participants will be encourage to practice what they learn at home in order to improve their mood or mental wellness.

Experimental: Young Professional Program

This is the young professional version of the program. The original program has been tailored to this population to meet its specific needs and address its specific concerns.

Behavioral: Mood Lifters
Participants will need to attend 12 hour long virtual weekly meetings on Zoom that focus on helpful mental health strategies and skills. Participants will be encourage to practice what they learn at home in order to improve their mood or mental wellness.

No Intervention: Waitlist

This is the waitlist. Participants may be randomly assigned here first. After the typical period fo the intervention on the waitlist (12 weeks), these participants will be invited to join the arm which they are most appropriate for (i.e., graduate student or young professional).

Outcome Measures

Primary Outcome Measures

  1. Patient Health Questionnaire - 9 [through study completion, an average of 1 year]

    Assesses Depressive Symptoms (Range 0-27; higher scores indicate more significant symptoms of depression)

  2. Generalized Anxiety Disorder - 7 [through study completion, an average of 1 year]

    Assesses Anxiety Symptoms (Range 0-21; higher scores indicate more significant symptoms of anxiety)

  3. Perceived Stress Scale [through study completion, an average of 1 year]

    Assesses Perceived stress (Range 0-40; higher scores indicate more significant perceived stress)

Eligibility Criteria

Criteria

Ages Eligible for Study:
22 Years to 32 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Participants ages 22-32 (must identify as either a graduate student or a young professional)
Exclusion Criteria:
  • Active suicidality, mania, or psychosis

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Michigan Ann Arbor Michigan United States 48103

Sponsors and Collaborators

  • University of Michigan

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Patricia Deldin, Professor of Psychology, University of Michigan
ClinicalTrials.gov Identifier:
NCT05078450
Other Study ID Numbers:
  • HUM00163570
First Posted:
Oct 14, 2021
Last Update Posted:
Oct 22, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 22, 2021